Pharmaceutical Industry

The FDA is putting off a decision on whether to approve a controversial drug that patient advocates and some senators say is the only hope for children with Duchenne Muscular Dystrophy. (iStock Photo)

Healthcare

FDA delays decision on controversial drug

May 25, 2016 4:16 pm

Two Republican senators, including Wisconsin Sen. Ron Johnson, are disappointed that a panel of experts did not recommend a new drug called Sarepta for Duchenne muscular dystrophy, a fatal disease that mainly affects young boys. (AP Photo/Susan Walsh, File)

Healthcare

Senators push FDA to approve drug for rare disease

Robert King -

May 23, 2016 10:15 pm

A majority of Americans don't want to sacrifice safety in exchange for getting new treatments faster to the market, a new poll finds. (AP Photo/Andrew Welsh-Huggins)

Healthcare

Americans prioritize safety over speedy drug approval, poll finds

Robert King -

May 11, 2016 2:51 pm

AARP said in comments on the proposed rule that were due Monday that seniors need relief from high drug prices. (FILE Bloomberg/Tannen Maury)

Healthcare

Drug industry, AARP fight over Medicare changes

Robert King -

May 10, 2016 4:01 am

—œPeople are raising issues that we need to think about,—? said Patrick Conway, who added that the agency will address their concerns. (AP Photo)

Healthcare

Administration defends controversial Medicare overhaul

Robert King -

May 4, 2016 4:00 pm

The agency issued an updated label for the antidepressant aripiprazole, the active ingredient in Abilify, Abilify Maintena and Aristada. (Bloomberg/Daniel Acker)

Healthcare

FDA: Antidepressant can cause gambling, binge eating, shopping and sex

Robert King -

May 3, 2016 9:22 pm

Editorial cartoons

Editorial cartoon: Rest in opioid

Washington Examiner -

May 3, 2016 7:00 pm

Shkreli is charged with using an investment fund to prop up the earnings for the Retrophin. (AP Photo/Susan Walsh, File)

Healthcare

Shkreli may face more charges

Robert King -

May 3, 2016 6:26 pm

Insurers still have ways of imposing undue costs and burdens on customers — particularly those suffering from chronic and serious health conditions. (iStock photo)

Healthcare

It’s time to end all types of healthcare discrimination

Carl Schmid -

May 2, 2016 4:03 am

Sens. Susan Collins, R-Maine, and Claire McCaskill, D-Mo., filed legislation in March calling for the agency to change the way it prioritizes generic drug applications. (AP Photo/Manuel Balce Ceneta)

Healthcare

FDA takes aim at high-priced generics

Robert King -

May 2, 2016 4:01 am

1...123124125...157 Page 124 of 157

Tag: Pharmaceutical Industry

FDA delays decision on controversial drug

Senators push FDA to approve drug for rare disease

Americans prioritize safety over speedy drug approval, poll finds

Drug industry, AARP fight over Medicare changes

Administration defends controversial Medicare overhaul

FDA: Antidepressant can cause gambling, binge eating, shopping and sex

Editorial cartoon: Rest in opioid

Shkreli may face more charges

It’s time to end all types of healthcare discrimination

FDA takes aim at high-priced generics

NEWS

POLICY

COMMENTARY

RESTORING AMERICA